NCT05967611

Brief Summary

This study will use electromyography and dynamometry to evaluate gluteal muscle activation during the Trendelenburg hip abduction test in different hip positions.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jul 2023

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 21, 2023

Completed
4 days until next milestone

Study Start

First participant enrolled

July 25, 2023

Completed
7 days until next milestone

First Posted

Study publicly available on registry

August 1, 2023

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 20, 2023

Completed
8 days until next milestone

Study Completion

Last participant's last visit for all outcomes

December 28, 2023

Completed
Last Updated

August 1, 2023

Status Verified

July 1, 2023

Enrollment Period

5 months

First QC Date

July 21, 2023

Last Update Submit

July 21, 2023

Conditions

Weakness, Muscle

Outcome Measures

Primary Outcomes (1)

  • Gluteus Medius Activation

    Mean EMG activity of the gluteus medius during the Trendelenburg test at different hip positions. Measured bilaterally in microvolts (μV).

    Baseline

Secondary Outcomes (2)

  • Gluteus Minimus Activation during Trendelenburg Test

    Baseline

  • Hip Abduction Strength during Trendelenburg Test

    Baseline

Study Arms (1)

Healthy Adults

At least 30 healthy adult participants aged 18-45 years performing the Trendelenburg hip abduction test

Diagnostic Test: Trendelenburg hip abduction test

Interventions

Trendelenburg hip abduction testDIAGNOSTIC_TEST

The Trendelenburg test performed at different hip flexion, extension, adduction and abduction angles.

Healthy Adults

Eligibility Criteria

Age18 Years - 45 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Healthy men and women aged 18-45 recruited from the local community.

You may qualify if:

  • Healthy adults aged 18-45 years
  • No history of hip disorders

You may not qualify if:

  • Contraindications to EMG
  • Neurological or muscular disorders

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Outpatient clinic of faculty of physical therapy, Ahram Canadian University

Al Ḩayy Ath Thāmin, Giza Governorate, 3221405, Egypt

RECRUITING

MeSH Terms

Conditions

Muscle Weakness

Condition Hierarchy (Ancestors)

Muscular DiseasesMusculoskeletal DiseasesNeuromuscular ManifestationsNeurologic ManifestationsNervous System DiseasesPathologic ProcessesPathological Conditions, Signs and SymptomsSigns and Symptoms

Study Officials

  • Amal Fawzy, Ph.d

    Faculty of Physical Therapy, Ahram Canadian University

    STUDY DIRECTOR

Central Study Contacts

Mohamed M ElMeligie, Ph.d

CONTACT

+201064442032mohamed.elmeligie@acu.edu.eg

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer of Physical Therapy and Director of Electromyography Lab

Study Record Dates

First Submitted

July 21, 2023

First Posted

August 1, 2023

Study Start

July 25, 2023

Primary Completion

December 20, 2023

Study Completion

December 28, 2023

Last Updated

August 1, 2023

Record last verified: 2023-07

Data Sharing

IPD Sharing
Will not share

Locations

EG(1)